These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders. Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M. J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062 [Abstract] [Full Text] [Related]
3. Mice selected for high versus low stress reactivity: a new animal model for affective disorders. Touma C, Bunck M, Glasl L, Nussbaumer M, Palme R, Stein H, Wolferstätter M, Zeh R, Zimbelmann M, Holsboer F, Landgraf R. Psychoneuroendocrinology; 2008 Jul; 33(6):839-62. PubMed ID: 18502051 [Abstract] [Full Text] [Related]
5. Depression and endocrine disorders: focus on the thyroid and adrenal system. Musselman DL, Nemeroff CB. Br J Psychiatry Suppl; 1996 Jun; (30):123-8. PubMed ID: 8864158 [Abstract] [Full Text] [Related]
6. The stress system in the human brain in depression and neurodegeneration. Swaab DF, Bao AM, Lucassen PJ. Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533 [Abstract] [Full Text] [Related]
8. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function. Nikisch G. Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389 [Abstract] [Full Text] [Related]
10. Is cholinergic sensitivity a genetic marker for the affective disorders? Janowsky DS, Overstreet DH, Nurnberger JI. Am J Med Genet; 1994 Dec 15; 54(4):335-44. PubMed ID: 7726206 [Abstract] [Full Text] [Related]
13. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Bao AM, Hestiantoro A, Van Someren EJ, Swaab DF, Zhou JN. Brain; 2005 Jun 15; 128(Pt 6):1301-13. PubMed ID: 15705605 [Abstract] [Full Text] [Related]
14. A view on noradrenergic, hypothalamic-pituitary-adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: the reduced growth hormone response to clonidine. Coplan JD, Pine DS, Papp LA, Gorman JM. Psychopharmacol Bull; 1997 Jun 15; 33(2):193-204. PubMed ID: 9230631 [No Abstract] [Full Text] [Related]
15. Subclinical psychopathology and socio-economic status in unaffected twins discordant for affective disorder. Christensen MV, Kyvik KO, Kessing LV. J Psychiatr Res; 2007 Jun 15; 41(3-4):229-38. PubMed ID: 16563437 [Abstract] [Full Text] [Related]
16. Susceptibility to depression expressed as alterations in cortisol day curve: a cross-twin, cross-trait study. Wichers MC, Myin-Germeys I, Jacobs N, Kenis G, Derom C, Vlietinck R, Delespaul P, Mengelers R, Peeters F, Nicolson N, Van Os J. Psychosom Med; 2008 Apr 15; 70(3):314-8. PubMed ID: 18378863 [Abstract] [Full Text] [Related]
19. The Munich vulnerability study on affective disorders: premorbid neuroendocrine profile of affected high-risk probands. Ising M, Lauer CJ, Holsboer F, Modell S. J Psychiatr Res; 2005 Jan 15; 39(1):21-8. PubMed ID: 15504420 [Abstract] [Full Text] [Related]